Development and validation of French version of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument

Clinical and Experimental Rheumatology

Volumn 29, Issue 2 SUPPL. 65, 2011, Pages

  Bae, S ^a   Allanore, Y ^b   Coustet, B ^b   Maranian, P ^a   Khanna, Dinesh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

French; Gastrointestinal; Quality of life; Questionnaire; Scleroderma; Systemic sclerosis; Ucla scleroderma gastrointestinal; UCLA SCTC GIT 2.0

Indexed keywords

ARTICLE; BLOATING; CLINICAL ASSESSMENT TOOL; CONSTIPATION; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE DURATION; EMOTIONALITY; FECES IMPACTION; FEMALE; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE DISTENSION; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; SOCIAL STATUS; SYSTEMIC SCLEROSIS; UCLA SCLERODERMA CLINICAL TRIAL CONSORTIUM GASTROINTESTINAL TRACT INSTRUMENT; WEIGHT REDUCTION; WELLBEING; ABDOMINAL DISTENSION; ADULT; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FECES INCONTINENCE; FRENCH (LANGUAGE); GASTROINTESTINAL DISEASE; INTERNAL CONSISTENCY; PSYCHOLOGICAL WELL-BEING; SOCIAL INTERACTION; TRANSLATING (LANGUAGE);

AGED; DIARRHEA; FECAL INCONTINENCE; FEMALE; FRANCE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TRANSLATIONS;

EID: 79960394853     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. LOCK, G, HOLSTEGE A, LANG B, SCHOLMERICH J: Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997; 92: 763-71.
2. BODUKAM, V, HAYS RD, MARANIAN P et al: Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology (Oxford); 2010.
3. THOMBS BD, HUDSON M, TAILLEFER SS, BARON M: Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 2008; 59: 504-9.
4. NIETERT PJ, MITCHELL HC, BOLSTER MB et al.: Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005; 32: 51-7.
5. KHANNA D, HAYS RD, MARANIAN P et al.: Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009; 61: 1257-63.
6. KHANNA D, HAYS RD, PARK GS et al.: Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 2007; 57: 1280-6.
7. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
8. WARE JE JR, SHERBOURNE CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
9. KHANNA D, FURST DE, CLEMENTS PJ et al.: Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005; 32: 832-40.
10. LEPLEGE A, ECOSSE E, VERDIER A, PERNEGER TV: The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998. 51: 1013-23.
11. GEORGES C, CHASSANY O, MOUTHON L et al.: [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]. Rev Med Interne 2004; 25: 16-21.
12. WARE JE JR, GANDEK B, KOSINSKI M et al.: The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1167-70.
13. BEATON DE, BOMBARDIER C, GUILLEMIN F, FERRAZ MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila, PA 1976), 2000; 25: 3186-91.
14. BLAND JM, ALTMAN DG: Cronbach's alpha. BMJ 1997; 314: 572.
15. COHEN J: Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. 2003, Mahwah, NJ: Erlbaum L Associates, xxviii, 703 p.
16. JOHNSON SR, GLAMAN DD, SCHENTAG CT, LEE P: Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006; 33: 1117-22.
17. SALLAM H, MCNEARNEY TA, CHEN JD: Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006; 23: 691-712.
18. KHANNA D, DENTON CP: Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010; 24: 387-400.